News & Media Catch up with our latest releases here. Filter Article 56 Podcast 3 Video 26 Video Rob Bennett 06/01/2023 Video Rob Bennett 06/01/2023 Oxford Cannabinoid Technologies "ready to go" after phase 1 trial submission Read More Video Rob Bennett 14/11/2022 Video Rob Bennett 14/11/2022 Oxford Cannabinoid Technologies nearly ready for new Phase 1 trial Read More Article Rob Bennett 26/07/2022 Article Rob Bennett 26/07/2022 Oxford Cannabinoid Technologies has good opportunities in both lead products says analyst Read More Article Rob Bennett 20/06/2022 Article Rob Bennett 20/06/2022 Outsourcing in Clinical Trials UK & Ireland 2022 Conference – Dr Valentino Parravicini’s Address Read More Video Rob Bennett 30/05/2022 Video Rob Bennett 30/05/2022 OCT Investor Update 30 May 2022 - Q&A Questions Read More Podcast Rob Bennett 18/05/2022 Podcast Rob Bennett 18/05/2022 The Cannabis Conversation: Cannabis Vs. Opioids with Valentino Parravicini Read More Article Rob Bennett 16/05/2022 Article Rob Bennett 16/05/2022 Investor Meet Company Q&A Session Read More Article Rob Bennett 25/04/2022 Article Rob Bennett 25/04/2022 Oxford Cannabinoid Technologies Announces Formation of Scientific Advisory Board to Support Clinical Strategy Read More Article Rob Bennett 31/03/2022 Article Rob Bennett 31/03/2022 Updates on Lead Programme 1 (OCT461201) and Programme 2 (OCT130401) - Trigeminal Neuralgia Clinical Trial Read More Video Rob Bennett 08/03/2022 Video Rob Bennett 08/03/2022 Data from pre-clinical study show positive results Read More Article Rob Bennett 04/03/2022 Article Rob Bennett 04/03/2022 Requisition of General Meeting - Update Read More Video Rob Bennett 24/02/2022 Video Rob Bennett 24/02/2022 Oxford Cannabinoid Technologies aims to get aggressive share of £42.5bln market by 2027 Read More Article Rob Bennett 18/02/2022 Article Rob Bennett 18/02/2022 Requisition of General Meeting Read More Article Rob Bennett 17/02/2022 Article Rob Bennett 17/02/2022 Notice of Analyst and Investment Presentation - How to Register Read More Article Rob Bennett 18/11/2021 Article Rob Bennett 18/11/2021 Oxford Cannabinoid Technologies in drug development deal with Oxford StemTech Read More Article Rob Bennett 17/11/2021 Article Rob Bennett 17/11/2021 Oxford Cannabinoid Technologies in drug development deal with Oxford StemTech Read More Article Rob Bennett 27/10/2021 Article Rob Bennett 27/10/2021 Posting of Annual Report, Notice of AGM and Form of Proxy Read More Video Rob Bennett 18/10/2021 Video Rob Bennett 18/10/2021 OCT Results and Company Update Read More Article Rob Bennett 12/10/2021 Article Rob Bennett 12/10/2021 Oxford Cannabinoid Technologies work on treatment for chronic, painful disease Trigeminal Neuralgia Read More Article Rob Bennett 11/10/2021 Article Rob Bennett 11/10/2021 Oxford Cannabinoid Technologies Targets Chronic Pain Condition with Latest Formulation Read More Newer Posts Older Posts
Video Rob Bennett 06/01/2023 Video Rob Bennett 06/01/2023 Oxford Cannabinoid Technologies "ready to go" after phase 1 trial submission Read More
Video Rob Bennett 14/11/2022 Video Rob Bennett 14/11/2022 Oxford Cannabinoid Technologies nearly ready for new Phase 1 trial Read More
Article Rob Bennett 26/07/2022 Article Rob Bennett 26/07/2022 Oxford Cannabinoid Technologies has good opportunities in both lead products says analyst Read More
Article Rob Bennett 20/06/2022 Article Rob Bennett 20/06/2022 Outsourcing in Clinical Trials UK & Ireland 2022 Conference – Dr Valentino Parravicini’s Address Read More
Video Rob Bennett 30/05/2022 Video Rob Bennett 30/05/2022 OCT Investor Update 30 May 2022 - Q&A Questions Read More
Podcast Rob Bennett 18/05/2022 Podcast Rob Bennett 18/05/2022 The Cannabis Conversation: Cannabis Vs. Opioids with Valentino Parravicini Read More
Article Rob Bennett 16/05/2022 Article Rob Bennett 16/05/2022 Investor Meet Company Q&A Session Read More
Article Rob Bennett 25/04/2022 Article Rob Bennett 25/04/2022 Oxford Cannabinoid Technologies Announces Formation of Scientific Advisory Board to Support Clinical Strategy Read More
Article Rob Bennett 31/03/2022 Article Rob Bennett 31/03/2022 Updates on Lead Programme 1 (OCT461201) and Programme 2 (OCT130401) - Trigeminal Neuralgia Clinical Trial Read More
Video Rob Bennett 08/03/2022 Video Rob Bennett 08/03/2022 Data from pre-clinical study show positive results Read More
Article Rob Bennett 04/03/2022 Article Rob Bennett 04/03/2022 Requisition of General Meeting - Update Read More
Video Rob Bennett 24/02/2022 Video Rob Bennett 24/02/2022 Oxford Cannabinoid Technologies aims to get aggressive share of £42.5bln market by 2027 Read More
Article Rob Bennett 18/02/2022 Article Rob Bennett 18/02/2022 Requisition of General Meeting Read More
Article Rob Bennett 17/02/2022 Article Rob Bennett 17/02/2022 Notice of Analyst and Investment Presentation - How to Register Read More
Article Rob Bennett 18/11/2021 Article Rob Bennett 18/11/2021 Oxford Cannabinoid Technologies in drug development deal with Oxford StemTech Read More
Article Rob Bennett 17/11/2021 Article Rob Bennett 17/11/2021 Oxford Cannabinoid Technologies in drug development deal with Oxford StemTech Read More
Article Rob Bennett 27/10/2021 Article Rob Bennett 27/10/2021 Posting of Annual Report, Notice of AGM and Form of Proxy Read More
Article Rob Bennett 12/10/2021 Article Rob Bennett 12/10/2021 Oxford Cannabinoid Technologies work on treatment for chronic, painful disease Trigeminal Neuralgia Read More
Article Rob Bennett 11/10/2021 Article Rob Bennett 11/10/2021 Oxford Cannabinoid Technologies Targets Chronic Pain Condition with Latest Formulation Read More
